Abstract:Circadian clocks are endogenous time-keeping systems that temporally organize biological processes. Gating of cell cycle events by a circadian clock is a universal observation that is currently considered a mechanism serving to protect DNA from diurnal exposure to ultraviolet radiation or other mutagens. In this study, we put forward another possibility: that such gating helps to insulate the circadian clock from perturbations induced by transcriptional inhibition during the M phase of the cell cycle. We introduced a periodic pulse of transcriptional inhibition into a previously published mammalian circadian model and simulated the behavior of the modified model under both constant darkness and light-dark cycle conditions. The simulation results under constant darkness indicated that periodic transcriptional inhibition could entrain/lock the circadian clock just as a light-dark cycle does. At equilibrium states, a transcriptional inhibition pulse of certain periods was always locked close to certain circadian phases where inhibition on Per and Bmal1 mRNA synthesis was most balanced. In a light-dark cycle condition, inhibitions imposed at different parts of a circadian period induced different degrees of perturbation to the circadian clock. When imposed at the middle- or late-night phase, the transcriptional inhibition cycle induced the least perturbations to the circadian clock. The late-night time window of least perturbation overlapped with the experimentally observed time window, where mitosis is most frequent. This supports our hypothesis that the circadian clock gates the cell cycle M phase to certain circadian phases to minimize perturbations induced by the latter. This study reveals the hidden effects of the cell division cycle on the circadian clock and, together with the current picture of genome stability maintenance by circadian gating of cell cycle, provides a more comprehensive understanding of the phenomenon of circading gating of cell cycle.

Modulation of Cl− Channel by Cell Cycle Clock

Molecular Characterization of a Cdna Encoding Na+/K+/2Cl− Cotransporter in the Gill of Mud Crab (scylla Paramamosain) During the Molt Cycle: Implication of Its Function in Osmoregulation

Functional Study Of Cbs Domain Interaction During Common Gating Of Clc-0 Chloride Channel

The Chloride Channel Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Controls Cellular Quiescence by Hyperpolarizing the Cell Membrane During Diapause in the Crustacean Artemia.

Characterization of a novel voltage-dependent outwardly rectifying anion current in Caenorhabditis elegans oocytes

Cyclin-dependent kinase 5 (Cdk5) activity is modulated by light and gates rapid phase shifts of the circadian clock

CryoEM structures of the human CLC-2 voltage-gated chloride channel reveal a ball-and-chain gating mechanism

Ion Transit Pathways and Gating in ClC Chloride Channels

CLOCK evolved in cnidaria to synchronize internal rhythms with diel environmental cues

Circadian rhythm regulation by pacemaker neuron chloride oscillation in flies

Modeling the Effects of Cell Cycle M-phase Transcriptional Inhibition on Circadian Oscillation.

Molecular mechanism underlying regulation of Arabidopsis CLCa transporter by nucleotides and phospholipids

Forkhead box protein A1 is a prognostic predictor and promotes tumor growth of gastric cancer

Putative Pacemakers in Crayfish Procambarus clarkii Show Circadian Oscillations in Levels of mRNA for Clock Genes under Different Light Rhythm

EXPERIMENTAL CHEMICAL PNEUMONIA

Circadian regulation of ion channels and their functions

Preparation and characterisation of homogeneous neurotoxin type A from Clostridium botulinum. Its inhibitory action on neuronal release of acetylcholine in the absence and presence of beta-bungarotoxin.

Insights into the function and regulation of the calcium-activated chloride channel TMEM16A

Stimulatory and inhibitory G-protein signaling relays drive cAMP accumulation for timely metamorphosis in the chordate Ciona

Mechanism of Ligand Activation of a Eukaryotic Cyclic Nucleotide−gated Channel

Oral Cobalamin Therapy for the Patient with Biermer’s Disease